GoKawiil
Tech News
Legend Biotech has appointed Ingrid Zhang, an executive from Novartis, as its new chief executive officer. She fills a leadership vacancy that opened in July after the company's previous CEO resigned abruptly.
As Moderna and Merck develop personalized cancer therapies, data and diagnostics firm Tempus AI is emerging as a key infrastructure player supporting that work. Personalis, a genomic testing company, sits at the center of this positioning, suggesting a broader supply-chain opportunity beyond the drugmakers themselves.